All In Biotech

Drug Trial Radar · NCT07233148

Healing ALS Registry Observational Study (HAROS)

Last checked: Nov 20, 2026Latest source record: Jun 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Jan 26, 2026

Primary completion

Feb 5, 2036

Study completion Mar 31, 2036

Sponsor

Lead sponsor
Healing Advocates Registry and MinistryAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 18, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 110 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Participants will enter information into an online ALS registry once per month, including their ALSFRS-R data, certain other symptoms, dietary intake, supplements, medications and other therapies, both conventional and integrative. Participants will also enter the hours spent on optional self-study and free online education. The investigators will assess the effectiveness of various therapies and education by measuring physical outcomes.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)
  • Motor Neuron Disease (MND)
  • Primary Lateral Sclerosis (PLS)

Interventions

  • Education about treatment optionsOther

    Education about treatment options and integrative therapies is optional. It is available online and is free for all study participants.

  • Dietary Supplements: Vitamins, Minerals, Herbs, etc.Dietary supplement

    The investigators are observing type and quantity of dietary supplements, vitamins, minerals and herbs that ALS/MND/PLS patients take regularly.

  • Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc.Behavioral

    Many of those diagnosed with ALS/MND/PLS regularly engage in meditation, prayer and other behavioral protocols. These will be observed and analyzed to see if, and to what degree they affect outcomes.

  • Diet, various diets will be observedOther

    May ALS/MND/PLS patients follow a specific diet such as ketogenic, vegetarian, gluten-free, dairy-free, and/or sugar-free. The investigators will analyze which diets are most efficacious.

  • Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapiesOther

    Exercise, physical therapy, occupational therapy, speech therapy, sauna, massage, EMS (electro-muscular stimulation), red light therapy and other physical modalities will be observed and analyzed for effect on outcomes.

  • ALS medications and other medicationsDrug

    Many ALS/MND/PLS patients find benefit from prescription and other drugs. These will be observed and analyzed for effect on quality of life and outcomes.

  • Physical and emotional supportOther

    Study participants are asked to record the level of emotional and physical support they get from family members, caregivers, friends, medical professionals and members of their community. The investigators will analyze how the perceived level of emotional and physical support affect outcomes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ALSFRS-R ALS Functional Rating Scale - RevisedTime frame: Participants will be assessed at baseline and each 1 year anniversary from the baseline until participant withdraws from the study for any reason, including death from any cause, up to a maximum of 10 years from baseline.
  2. ALSSQ ALS Supplementary QuestionnaireTime frame: Participants will be assessed at baseline and each 1 year anniversary from the baseline until participant withdraws from the study for any reason, including death from any cause, up to a maximum of 10 years from baseline.
  3. Mindset ScoreTime frame: Participants will be assessed at baseline and each 1 year anniversary from the baseline until participant withdraws from the study for any reason, including death from any cause, up to a maximum of 10 years from baseline.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Virtual

    Park City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.